» Articles » PMID: 21214332

Discrimination Between Low-grade Oligodendrogliomas and Diffuse Astrocytoma with the Aid of 11C-methionine Positron Emission Tomography

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2011 Jan 11
PMID 21214332
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Object: The diagnostic usefulness of (11)C-methionine PET scans in gliomas is still controversial. The authors investigated the clinical significance of (11)C-methionine PET findings in preoperative diagnosis of histological type and grade.

Methods: The tissue uptake of (11)C-methionine was assessed using PET in 70 patients with histologically confirmed intracerebral gliomas. The ratio of maximum standard uptake values in tumor areas to the mean standard uptake values in the contralateral normal brain tissue (tumor/normal tissue [T/N] ratio) was calculated and correlated with tumor type, histological grade, contrast enhancement on MR imaging, Ki 67 labeling index, and 1p/19q status.

Results: The T/N ratio was significantly increased as tumor grade advanced in astrocytic tumors (WHO Grade II vs Grade III, p = 0.0011; Grade III vs Grade IV, p = 0.0007). Among Grade II gliomas, the mean T/N ratio was significantly higher in oligodendroglial tumors than in diffuse astrocytomas (DAs) (p < 0.0001). All T/N ratios for oligodendroglial tumors were ≥ 1.46, and those for DA were consistently < 1.46, with the exception of 2 cases of gemistocytic astrocytoma. The Ki 67 labeling index significantly correlated with T/N ratio in astrocytic tumors, but not in oligodendrogliomas. Oligodendroglial tumors without 1p/19q deletion had a significantly higher T/N ratio than those with the codeletion. In combination with Gd-enhanced MR imaging, 67% of nonenhanced tumors with a T/N ratio of ≥ 1.46 were proved to be Grade II oligodendrogliomas.

Conclusions: These results clearly show that (11)C-methionine PET T/N ratios in Grade II oligodendrogliomas were higher than those in DAs independently of their proliferative activity. This information contributes to preoperative differential diagnoses of histological type, especially in suspected low-grade gliomas.

Citing Articles

Efficient Detection of Oligodendroglioma With 1p/19q Codeletion Mutation via Methionine PET Imaging: A Promising Diagnostic Approach.

Mateo-Nouel E, Mondragon-Soto M, Nicolas-Cruz C, Villanueva-Castro E, Rodriguez Hernandez L, Reyes-Moreno I Cureus. 2025; 17(1):e77826.

PMID: 39996200 PMC: 11848700. DOI: 10.7759/cureus.77826.


Higher Uptake of Preoperative 11C-Methionine Positron Emission Tomography Related to Preoperative Seizure in Patients With Oligodendroglioma.

Bajagain M, Sakamoto A, Takajo T, Makino R, Uchida H, Masuda K Cureus. 2025; 17(1):e76991.

PMID: 39917141 PMC: 11798757. DOI: 10.7759/cureus.76991.


The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density.

Yamashita K, Murayama R, Itoyama M, Kikuchi K, Kusunoki M, Kuga D Neuroradiology. 2025; 67(2):291-298.

PMID: 39831960 DOI: 10.1007/s00234-024-03538-1.


Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.

Zhou W, Wen J, Huang Q, Zeng Y, Zhou Z, Zhu Y Eur J Nucl Med Mol Imaging. 2023; 51(5):1423-1435.

PMID: 38110710 DOI: 10.1007/s00259-023-06562-0.


T2-FLAIR mismatch sign correlates with C-methionine uptake in lower-grade diffuse gliomas.

Ebiko Y, Tamura K, Hara S, Inaji M, Tanaka Y, Nariai T J Neurooncol. 2023; 164(1):257-265.

PMID: 37589920 DOI: 10.1007/s11060-023-04417-0.